Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Mammalian Cell Fermentation Technology Market Expected to Grow Between 2025 And 2029?

The market for mammalian cell fermentation technology has experienced a swift expansion in the past few years. It is projected to increase from a value of $51.29 billion in 2024 to $57.48 billion in 2025, representing a compound annual growth rate (CAGR) of 12.1%. The boom in the historical era can be traced back to the escalated demand for biologics and biosimilars, a heightened emphasis on personalized medicine, an increase in biopharmaceutical production, and a growing need for scalable and productive cell cultivation techniques.

What Growth Rate Is Anticipated for the Mammalian Cell Fermentation Technology Market in the Coming Years?

The market for mammalian cell fermentation technology is predicted to surge rapidly in the coming years, expanding to a value of $89.54 billion in 2029 with an 11.7% Compound Annual Growth Rate (CAGR). The anticipated market growth during this period could be ascribed to a rising prevalence of chronic ailments, increased financial commitment from multinational companies, the growing occurrence of chronic illnesses, the escalating use of advanced bioprocessing methods, augmented investment in the R&D of new recombinant proteins, and elevated demand for cancer treatments. Notable trends projected in this period encompass advancements in cell culture technology, progress in bioreactor design, the evolution of next-generation bioprocessing technologies, the fusion of multi-omics tactics, and the influence of technology on automation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Who Are the Leading Companies in the Mammalian Cell Fermentation Technology Market?

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

What Are the Key Drivers of the Mammalian Cell Fermentation Technology Market?

The mammalian cell fermentation technology market is predicted to grow due to the surge in demand for biologics. Biologics, medicinal products made from or containing components of living organisms, are often used to combat diseases such as cancer, autoimmune disorders, and infectious diseases. Their increasing demand is driven by advancements in biotechnology, their proven efficacy in managing widespread chronic ailments like cancer and autoimmune disorders, regulatory sanctioning, and increased investment in R&D. Mammalian cell fermentation technology is efficient in producing intricate biologics and is meeting the growing demand for individualized and targeted therapeutics. This technology’s scalability, adaptability, and ability to produce premium quality proteins are fuelling innovation in the biopharmaceutical sector. For example, as per the US-based National Library of Medicine, in February 2024, the FDA approved 55 new drugs in 2023, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This marks a 50% rise compared to the 37 approvals in 2022. Hence, the accelerating demand for biologics is fuelling the growth of the bacterial cell fermentation technology market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16473&type=smp

What Are the Key Market Segments in the Mammalian Cell Fermentation Technology Industry?

The mammalian cell fermentation technology market covered in this report is segmented –

1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types

2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications

3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes

What Are the Latest Trends in the Mammalian Cell Fermentation Technology Market?

Leading firms in the mammalian cell fermentation technology sector are striving to enhance their market standing by developing cutting-edge technologies like mammalian cell culture. Playing a vital role in areas like biomanufacturing, research, and regenerative medicine, a mammalian cell culture can be used to produce therapeutic proteins, vaccines, and functional cells or tissue replacements. Take for example, Syntegon, a biotech firm based in Germany, which in June 2024 unveiled its innovative Modular Bioprocessing Platform (MBP) during Achema 2024. This platform was created with the intention to solve main issues associated with biopharmaceutical manufacturing. The MBP caters to a wide array of applications, spanning microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The platform’s modular structure results in reduced lead times and costs, without sacrificing functionality or quality, a characteristic synonymous with the “made in Germany” stamp. The insightful design of its prefabricated cleanroom situates all auxiliary technology outside the cleanroom which increases efficiency and eases maintenance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

What Are the Key Regional Markets in the Mammalian Cell Fermentation Technology Industry?

North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16473

This Report Delivers Insight On:

1. How big is the mammalian cell fermentation technology market, and how is it changing globally?

2. Who are the major companies in the mammalian cell fermentation technology market, and how are they performing?

3. What are the key opportunities and risks in the mammalian cell fermentation technology market right now?

4. Which products or customer segments are growing the most in the mammalian cell fermentation technology market?

5. What factors are helping or slowing down the growth of the mammalian cell fermentation technology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model